TempraMed Announces Upsize to Offering #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #Technology #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESToronto, Ontario--(Newsfile Corp. - September 28, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) ("TempraMed" or the "Company") is pleased to announce an upsize (the "Upsized Offering") to the non-brokered private placement (the "Offering") previously announced on Wednesday, September 23, 2026. The Upsized Offering will include up to C$600,000 in unsecured convertible debentures (each, a...
http://dlvr.it/TVhKpY
http://dlvr.it/TVhKpY
Comments
Post a Comment